Overactive bladder (OAB) is a condition characterized by a sudden, difficult-to-control urge to urinate in the absence of urinary tract infection or other identifiable causes. The hallmark symptom is urgency, often accompanied by frequent daytime urination and nocturia (waking multiple times at night to urinate). Even when only a small amount of urine accumulates in the bladder, involuntary contractions of the detrusor muscle can trigger the urge to void, making it difficult for patients to maintain control. Because the exact cause of OAB is not always clearly understood, definitive treatment can be challenging.
First-line treatment typically involves medication. Drugs are prescribed to reduce bladder overactivity or decrease sensitivity, helping to control urgency and frequency. Behavioral therapies, including bladder training and biofeedback, are often used alongside medication to improve outcomes.
However, when symptoms do not respond adequately to these treatments, intravesical botulinum toxin (Botox) injection may be considered. Botulinum toxin works by inhibiting the release of acetylcholine at nerve endings, thereby reducing excessive muscle contractions. Produced by the bacterium Clostridium botulinum, this toxin can be injected into the bladder muscle to help alleviate symptoms of OAB. In simple terms, it blocks the signals that cause the bladder muscle to contract excessively.
The procedure is performed using cystoscopy through the urethra, typically under local or regional anesthesia. The physician visualizes the bladder with an endoscope and injects botulinum toxin into multiple sites in the bladder wall. The procedure usually takes about 10 to 15 minutes and is generally well tolerated with minimal discomfort. A typical dose is around 100 units, which can be adjusted based on the patient’s condition. The therapeutic effect usually begins within two weeks and lasts approximately 6 to 10 months.
There are important considerations associated with this treatment. In some cases, bladder contractility may become too weak after injection, leading to difficulty in urination. Patients may need to perform intermittent self-catheterization if this occurs. Other potential side effects include urinary tract infection, mild bleeding, or discomfort. Therefore, thorough evaluation and consultation are essential before undergoing the procedure.
According to recent data, the number of patients diagnosed with overactive bladder has increased significantly, rising by approximately 57% over the past five years. OAB can significantly impact daily life, including activities such as long-distance driving or work performance. If symptoms persist despite long-term medication, procedural options such as bladder Botox injection may provide an effective alternative.
While overactive bladder is not life-threatening, it can substantially reduce quality of life. Early evaluation and appropriate treatment can help patients regain control and improve daily functioning.